CN Mobile Logo

Search form



Reviews and Perspectives for the Practicing Oncologist
Featured Article

What’s New in Genetic Testing for Cancer Susceptibility?

Jennifer K. Plichta, MD, Molly Griffin, BA, Joseph Thakuria, MD, and Kevin S. Hughes, MD

The dilemma for clinicians is how best to understand and manage this rapidly growing body of information to improve patient care. With millions of genetic variants of potential clinical significance and thousands of genes associated with rare but well-established genetic conditions, the complexities of genetic data management clearly will require improved computerized clinical decision support tools, as opposed to continued reliance on traditional rote, memory-based medicine.


September 2016 Table of Contents

Volume 30 | Number 9

Current Trends in the Management of Ductal Carcinoma In Situ
Tristen S. Park, MD, and E. Shelley Hwang, MD, MPH

Data on Ductal Carcinoma In Situ Encumbered by Opinion

Next Generation of Targeted Molecules for Non-Hodgkin Lymphomas: Small-Molecule Inhibitors of Intracellular Targets and Signaling Pathways
Hannah Choe, MD, and Jia Ruan, MD, PhD

How Do Targeted Therapies Change the Management of Indolent Lymphomas?

What’s New in Genetic Testing for Cancer Susceptibility?
Jennifer K. Plichta, MD, Molly Griffin, BA, Joseph Thakuria, MD, and Kevin S. Hughes, MD

Ready, Fire, Aim: Addressing Issues Associated With Multigene Panel Testing for Cancer Susceptibility


ACR Appropriateness Criteria® Adjuvant Management of Early-Stage Endometrial Cancer
Andrew O. Wahl, MD, David K. Gaffney, MD, PhD, Anuja Jhingran, MD, et al

How an Expert Approaches It

Third-Line Treatment Options for Kidney Cancer
Edwin M. Posadas, MD, Suwicha Limvorasak, PharmD, and Robert A. Figlin, MD


When to Use Prophylactic Antibiotics in Neutropenic Patients
Andrea Zimmer, MD, and Alison Freifeld, MD


Laura Esserman and Ian Thompson Discuss Strategies for Screening and Treatment of Early-Stage Cancers, and How Clinicians Can Learn From Each Other’s Experiences


Rising PSA Level in an Anxious Postprostatectomy Patient
Robert Qi, and Judd W. Moul, MD



Julie VoseJulie M. Vose, MDUniversity of Nebraska Medical School Omaha, Nebraska
Editor-in-Chief, ONCOLOGY
Nora JanjanNora Janjan, MD, MPSA, MBA Senior Fellow for Healthcare Policy, National Center for Policy Analysis
Editor-in-Chief, ONCOLOGY
William C. Wood, MDWilliam C. Wood, MD Department of Surgery, Emory University School of Medicine, Atlanta, Georgia
Editor-in-Chief, ONCOLOGY
Nancy E. Davidson, MDNancy E. Davidson, MD University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania UPMC CancerCenter, Pittsburgh
Editor-in-Chief, ONCOLOGY


By clicking Accept, you agree to become a member of the UBM Medica Community.